Cannabis Radio News

DEA Approves Syndros® THC Oral Solution as Schedule II

March 23, 20174 min
DEA Approves Syndros® THC Oral Solution as the new pharmaceutical drug has received approval for placement in Schedule II classification by the DEA.

Chat About DEA Approves Syndros® THC Oral Solution as Schedule II